Business Wire

Research and Markets: DNA Sequencing and PCR Markets

Research and Markets: DNA Sequencing and PCR Markets – over $4.5 Billion Was Spent Worldwide in 2003 on Industrial and Academic Research to Understand Human Gene Function

Business Editors/Health/Medical Writers

DUBLIN, Ireland–(BUSINESS WIRE)–April 21, 2004

Research and Markets ( has announced the addition of DNA Sequencing and PCR Markets to their offering.

Genetic analysis has become one of the most important laboratory techniques in the life sciences. The massive effort to sequence the human genome is paralleled by projects to sequence the genomes of infectious organisms, research animals including fruit flies, worms and rats, and important food crops. It is estimated that over $4.5 billion was spent worldwide in 2003 on industrial and academic research to understand human gene function. This report describes the worldwide market for DNA sequencing and analysis products, which consists of reagents, assays and other consumables. The total market for molecular diagnostics products of all kinds is an important part of the overall sequencing market, and is described in detail.

The emphasis in this report is on DNA sequencing reagents and equipment primarily used in the life sciences. Life scientists are spread throughout academia, in hospitals and medical schools, as well as in industry and government laboratories and private research foundations. Most often, they are working in the fields of molecular biology, cell biology, and biotechnology, as well as specialties such as bioinformatics, cancer research, proteomics, genetic disease, immunology, and microbiology. As a group, these life scientists most frequently use amplification techniques.The fastest growing category of custom laboratory services is qualitative PCR services.

Reagents and Equipment for use in DNA sequencing is analyzed worldwide with the sequencing of DNA for pharmaceutical, biotech, industrial and diagnostic development, growth in this sector is forecast, with total market size predicted through 2010.

The niche of chip-based sequencers is described and predictions for annual growth and market size are made to 2010. The market for protein sequencing instrumentation is developing more slowly, but is described in detail.

The leader in this business, the Applied Biosystems division of Applera Corporation achieves the majority of its revenues from DNA sequencing technologies. The company has installed over 10,000 automated sequencers in the past decade and has over 70% of the market. By mid-2003, PE had over 1700 orders for its $300,000 ABI PRISM 3700 DNA analyzer, or 1475 excluding those from its sister divion of Applera, Celera Genomics business unit.

Applied Biosystems continues to strengthen its leadership in this field. Other leading players described include Amersham Pharmacia Biosystems, Beckman and their purchase of Genomyx and HP’s with its extensive collaborative agreements with Chiroscience to develop MS sequencing technologies and with Affymetrix on the GeneArray system.

Companies developing or marketing competitive DNA array technology include like Affymetrix, Agilent Technologies, Inc., Amersham Biosciences K.K., Applied Biosystems, Inc., Axon Instruments, Inc., BD Biosciences Clontech, CombiMatrix Corporation, Digital Gene Technologies, Inc., febit ag, Illumina, Inc., Lynx Therapeutics, Inc., Nanogen, Inc., NimbleGen Systems, Inc., Sequenom, Inc., Xeotron, Inc., and Visible Genetics Inc. (recently acquired by Bayer) are profiled, together with over 50 other players in the segment.

The DNA/PCR kit market for the research segment is highly fragmented and full of competitors. The report outlines the largest players and estimated market share in this segment. The key bioassay technologies in the life sciences industry are summarized and described.

The purpose of this report is to describe the specific market segment of the in life sciences market DNA sequencing. This report includes all of the generally accepted DNA oriented analytical activities that are currently used today. It examines these measurement technology platforms and their reagents and supplies as utilized in research, biotech, pharmaceutical and health care.

This report seeks to:

– Identify viable technology drivers through a comprehensive look at various platform technologies for molecular sequenching, including immunoassays electrophoretic methods, probe-based nucleic acid assays, microarrays, and non-PCR sequencing

– Discover feasible market opportunities via an identification of high-growth applications in different sequencing areas, with a focus on the biggest and expanding markets new technology platforms.

– Focus on global industry development through an in-depth analysis of the major world markets for molecular sequencing, including forecasts for growth.

This report concentrates on the molecular sequencing market segment in important worldwide markets such as the U.S., Japan and Europe, including Germany, the U.K., and other countries of the big five. It focuses primarily on the research, pharma and biotech market segment, and, separately, on a description of the instruments, reagents and supplies marketed by major companies in this segment. The report discusses the market size, growth rates, and market components for instruments and reagents, controls, and consumables used in this area.

For more information visit

COPYRIGHT 2004 Business Wire

COPYRIGHT 2004 Gale Group